Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for …
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
This week | ||
AGEN Stock Jumps on Securing $340M Financing to Fund Strategic Pivot Agenus surges after securing up to $340M in financing to fund its phase III ROBBIN colon cancer study and extend its cash runway if warrants are exercised. | ||
Agenus (AGEN) Moves 82.7% Higher: Will This Strength Last? Agenus (AGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. | ||
Agenus shares surge as company secures up to $340M to advance colon cancer trial Agenus (Agenus Inc (NASDAQ:AGEN)) shares jumped about 100% on Monday after the biotechnology company announced an oversubscribed private placement of up to $340 million to support development of its botensilimab and balstilimab (BOT+BAL) immunotherapy combination in microsatellite-stable (MSS)... | ||
3 Overlooked Stocks Positioned for the Next Market Rotation Oxford Club strategist Marc Lichtenfeld highlights diversification beyond tech, spotlighting Ligand Pharmaceuticals, Aflac and Atlantic Union Bankshares as healthcare, insurance and banking stocks gaining quiet momentum. | ||
Agenus Shares Rise After Securing Up to $340 Million Financing Package (AGEN) Private Placement Strengthens Funding PositionAgenus Inc. (NASDAQ:AGEN) shares climbed 13% in premarket trading on Monday after the biotechnology company announced an $85 million private placement designed to strengthen its balance sheet and support the continued development of its clinical pipeline. | ||
Older | ||